Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000950170-25-058690
Filing Date
2025-04-25
Accepted
2025-04-25 16:03:07
Documents
15
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A svra-20241231.htm   iXBRL 10-K/A 172592
2 EX-19.1 svra-ex19_1.htm EX-19.1 132070
3 EX-31.1 svra-ex31_1.htm EX-31.1 6217
4 EX-31.2 svra-ex31_2.htm EX-31.2 6608
5 GRAPHIC img199040218_0.jpg GRAPHIC 5538
  Complete submission text file 0000950170-25-058690.txt   566162

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT svra-20241231.xsd EX-101.SCH 54582
17 EXTRACTED XBRL INSTANCE DOCUMENT svra-20241231_htm.xml XML 10433
Mailing Address 6836 BEE CAVE ROAD BUILDING 3, SUITE 201 AUSTIN TX 78746
Business Address 6836 BEE CAVE ROAD BUILDING 3, SUITE 201 AUSTIN TX 78746 51285113796
Savara Inc (Filer) CIK: 0001160308 (see all company filings)

EIN.: 841318182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-32157 | Film No.: 25873718
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)